Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J. Joyner, Arturo Casadevall, Vitaly Herasevich et al.|New England Journal of Medicine|2021Cited by 553
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J. Joyner, Arturo Casadevall, R. Scott Wright et al.|Journal of Clinical Investigation|2020Cited by 485
Safety UpdateMichael J. Joyner, R. Scott Wright, Katelyn A. Bruno et al.|Mayo Clinic Proceedings|2020Cited by 432
Secondary Cancers after Chimeric Antigen Receptor T-Cell TherapyNicole Verdun, Peter Marks|New England Journal of Medicine|2024Cited by 257
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry studyJonathon W. Senefeld, Janis E. Blair, Patrick W. Johnson et al.|PLoS Medicine|2021Cited by 65